The company's manufacturing facilities are located in the USA, Sweden and Germany. Repligen markets its products globally through a direct commercial organization in the USA, Europe and Asia, as well as through strategic partners in certain markets.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze